Have a personal or library account? Click to login
Use of Circulating and Cellular miRNAs Expression in Forensic Sciences Cover

References

  1. 1. Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem. 2009;387:303-314.10.1016/j.ab.2009.01.03719454234
  2. 2. Verduijn R. Recent Developments in Forensic Biology. BSc Biol. 2010.
  3. 3. Petersen CH, Hjort BB, Tvedebrink T, Kielpinski LJ, Vinther J, Morling N. Body fluid identification of blood, saliva and semen using second generation sequencing of micro-RNA. Forensic Sci Int Genet Suppl Ser. 2013;4:e204-e205.10.1016/j.fsigss.2013.10.105
  4. 4. Wang Z, Zhang J, Luo H, Ye Y, Yan J, Hou Y. Screening and confirmation of microRNA markers for forensic body fluid identification. Forensic Sci Int Genet. 2013;7:116-123.10.1016/j.fsigen.2012.07.00622909992
  5. 5. Meng L, Chen L, Li Z, Wu Z-X, Shan G. Roles of microRNAs in the Caenorhabditis elegans nervous system. J Genet Genomics. 2013;40:445-452.10.1016/j.jgg.2013.07.00224053946
  6. 6. Zubakov D, Boersma AWM, Choi Y, Van Kuijk PF, Wiemer EC, Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med. 2010;124:217-226.10.1007/s00414-009-0402-3285501520145944
  7. 7. Wang Z, Luo H, Pan X, Liao M, Hou Y. A model for data analysis of microRNA expression in forensic body fluid identification. Forensic Sci Int Genet. 2012;6:419-423.10.1016/j.fsigen.2011.08.00821903498
  8. 8. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012;53:64-72.10.1016/j.yjmcc.2012.04.00322525256
  9. 9. Guo HQ, Huang GL, Guo CC, Pu XX, Lin TY. Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma. Dis Markers. 2010;29:251-258.10.1155/2010/474692
  10. 10. Deng H, Guo Y, Song H, et al. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene. 2013;518:351-359.10.1016/j.gene.2012.12.10323333942
  11. 11. Uhlich RM, Konie JA, Davis JW, et al. Novel microRNA correlations in the severely injured. Surgery. 2014;156:834-840.10.1016/j.surg.2014.06.01725239329
  12. 12. Liu T, Cheng W, Gao Y, Wang H, Liu Z. Microarray analysis of microRNA expression patterns in the semen of infertile men with semen abnormalities. Mol Med Rep. 2012;6:535-542.10.3892/mmr.2012.96722735917
  13. 13. Chen W, Harbeck MC, Zhang W, Jacobson JR. MicroRNA regulation of integrins. Transl Res. 2013;162:133-143.10.1016/j.trsl.2013.06.008382555423859989
  14. 14. Abdelmohsen K, Srikantan S, Kang MJ, Gorospe M. Regulation of senescence by microRNA biogenesis factors. Ageing Res Rev. 2012;11:491-500.10.1016/j.arr.2012.01.003334899522306790
  15. 15. Westholm JO, Lai EC. Mirtrons: microRNA biogenesis via splicing. Biochimie. 2011;93:1897-1904.10.1016/j.biochi.2011.06.017318518921712066
  16. 16. Von Brandenstein M, Richter C, Fries JWU. MicroRNAs: Small but amazing, and their association with endothelin. Life Sci. 2012;91:475-489.10.1016/j.lfs.2012.06.02522771694
  17. 17. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17:3011-3016.10.1101/gad.115880330525214681208
  18. 18. Cheng G. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev. 2015;81:75-93.10.1016/j.addr.2014.09.00125220354
  19. 19. Andersen HH, Duroux M, Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis. 2014;71:159-168.10.1016/j.nbd.2014.08.00325119878
  20. 20. Weilner S, Schraml E, Redl H, Grillari-Voglauer R, Grillari J. Secretion of microvesicular miRNAs in cellular and organismal aging. Exp Gerontol. 2013;48:626-633.10.1016/j.exger.2012.11.017369556623283304
  21. 21. Rana S, Malinowska K, Zöller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia. 2013;15:281-295.10.1593/neo.122010359315123479506
  22. 22. Dumache R, Rogobete AF, Bedreag OH, et al. Use of miRNAs as biomarkers in sepsis. Anal Cell Pathol (Amst). 2015;2015:186716.10.1155/2015/186716449937526221578
  23. 23. Weber J, Baxter DH, Zhang S, et al. The MicroRNA Spectrum in 12 Body Fluids. Clin Chem. 2010;56:1733-1741.10.1373/clinchem.2010.147405484627620847327
  24. 24. Hanson E, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Forensic Sci Int Genet Suppl Ser. 2009;2:503-504.10.1016/j.fsigss.2009.08.184
  25. 25. Williams G, Uchimoto ML, Coult N, World D, Beasley E, Avenell P. Characterisation of body fluid specific microRNA markers by capillary electrophoresis. Forensic Sci Int Genet Suppl Ser. 2013;4:e274-e275.10.1016/j.fsigss.2013.10.140
  26. 26. Kuner R, Brase JC, Sültmann H, Wuttig D: microRNA biomarkers in body fluids of prostate cancer patients. Methods. 2013;59:132-137.10.1016/j.ymeth.2012.05.00422652624
  27. 27. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:1-7.10.1371/journal.pone.0003148251978918773077
  28. 28. Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010;12:R90.10.1186/bcr2766304642921047409
  29. 29. Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L. Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep. 2014;4.10.1038/srep05150538149024889152
  30. 30. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA. 2006;103:2746-2751.10.1073/pnas.0511045103141382016477010
  31. 31. Bloomston M, WL F, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901-1908.10.1001/jama.297.17.190117473300
  32. 32. Tsai HL, Yang IP, Huang CW, et al. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection. Transl Res. 2013;162:258-268.10.1016/j.trsl.2013.07.00923933284
  33. 33. Harraz MM, Dawson TM, Dawson VL. MicroRNAs in Parkinson’s disease. J Chem Neuroanat. 2011;42:127-130.10.1016/j.jchemneu.2011.01.005316381321295133
  34. 34. Papurica M, Rogobete AF, Sandesc D, et al. Advances in Biomarkers in Critical Ill Polytrauma Patients. Clin Lab. 2016;62:977-986.10.7754/Clin.Lab.2015.15110327468558
  35. 35. Jones K, Nourse JP, Keane C, Bhatnagar A, Gandhi MK. Plasma microRNA are disease response biomarkers in classical hodgkin lymphoma. Clinical Cancer Research. 2014;20:253-264.10.1158/1078-0432.CCR-13-102424222179
  36. 36. Yang X, Salminen WF, Shi Q, et al. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol. 2015;284:180-187.10.1016/j.taap.2015.02.013455862225708609
  37. 37. Wang F, Li C, Liu W, Jin Y. Effect of exposure to volatile organic compounds (VOCs) on airway inflammatory response in mice. J Toxicol Sci. 2012;37:739-748.10.2131/jts.37.73922863854
  38. 38. Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumor Biol. 2011;32:179-188.10.1007/s13277-010-0111-z20857258
  39. 39. Bollati V, Marinelli B, Apostoli P, et al. Exposure to metal-rich particulate matter modifies the expression of candidate MicroRNAs in peripheral blood leukocytes. Environ Health Perspect. 2010;118:763-768.10.1289/ehp.0901300289885120061215
  40. 40. Avissar-Whiting M, Veiga KR, et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol. 2010;29:401-406.10.1016/j.reprotox.2010.04.004289687520417706
  41. 41. Singh NP, Singh UP, Guan H, Nagarkatti P, Nagarkatti M. Prenatal Exposure to TCDD Triggers Significant Modulation of microRNA Expression Profile in the Thymus That Affects Consequent Gene Expression. PLoS One. 2012;7:e45054.10.1371/journal.pone.0045054344320823024791
  42. 42. Liu R, Zhang C, Hu Z, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784-791.10.1016/j.ejca.2010.10.02521112772
  43. 43. Zhang X, Cui L, Ye G, et al. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumor Biol. 2012;33:2349-2355.10.1007/s13277-012-0497-x22926798
  44. 44. Song MY, Pan KF, Su HJ, et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One. 2012;7:1-9.10.1371/journal.pone.0033608330385622432036
  45. 45. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127:118-126.10.1002/ijc.2500719876917
  46. 46. Zhu C, Tsao M. Prognostic markers in lung cancer: is it ready for prime time? Transl Lung Cancer Res. 2014;3:149-158.
  47. 47. Wang P, Yang D, Zhang H, et al. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers. Clin Lung Cancer. 2014;16:313-319. e110.1016/j.cllc.2014.12.00625639977
  48. 48. Rehbein G, Schmidt B, Fleischhacker M. Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer. Clin Chim Acta. 2015;450:78-82.10.1016/j.cca.2015.07.02726232753
  49. 49. Powrózek T, Krawczyk P, Kowalski DM, Winiarczyk K, Olszyna-Serementa M, Milanowski J. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. Transl Res. 2015;166:315-323.10.1016/j.trsl.2015.05.00926079400
  50. 50. Zhou J, Yu L, Gao X, et al. Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma. J Clin Oncol. 2011;29:4781-4788.10.1200/JCO.2011.38.269722105822
  51. 51. Vincent L, Vang D, Nguyen J, et al. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood. 2013;122:1853-1862.10.1182/blood-2013-04-498105377249523775718
  52. 52. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-10518.10.1073/pnas.0804549105249247218663219
  53. 53. Redova M, Sana J, Slaby O. Circulating miRNAs as new blood-based biomarkers for solid cancers. Futur Oncol. 2013;9:387-402.10.2217/fon.12.19223469974
  54. 54. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: The oxidative stress link. Eur Respir J. 2009;33:1467-1484.10.1183/09031936.0008660819483049
  55. 55. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684.10.1161/CIRCRESAHA.109.21556620595655
  56. 56. Weber M, Baker MB, Patel RS, Quyyumi AA, Bao G, Searles CD. MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. Card Res Pract. 2011;2011:532915.10.4061/2011/532915313798721785714
  57. 57. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010;119:87-95.10.1042/CS20090645359381520218970
  58. 58. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010;391:73-77.10.1016/j.bbrc.2009.11.00519896465
  59. 59. Olivieri F, Antonicelli R, Lorenzi M, et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol. 2013;167:531-536.10.1016/j.ijcard.2012.01.07522330002
  60. 60. Cogswell JP, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14:27-41.10.3233/JAD-2008-14103
  61. 61. Karolina DS, Armugam A, Tavintharan S, et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011;6.10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622
  62. 62. Bedreag OH, Sandesc D, Chiriac SD, et al. The Use of Circulating miRNAs as Biomarkers for Oxidative Stress in Critically Ill Polytrauma Patients. Clin Lab. 2016;62:263-274.10.7754/Clin.Lab.2015.150740
  63. 63. Sun T, Chen X, Liu Z, et al. Expression profiling of MicroRNAs in hippocampus of rats following traumatic brain injury. J Huazhong Univ Sci Technol Medical Sci. 2014;34:548-553.10.1007/s11596-014-1313-125135725
  64. 64. Butcher N, Balogh ZJ. The definition of polytrauma: the need for international consensus. Injury. 2009;40:S12-S22.10.1016/j.injury.2009.10.03219895948
  65. 65. Liu NK, Wang XF, Lu B, Xu XM. Altered microRNA expression following traumatic spinal cord injury. Exp Neurol. 2009;219:424-429.10.1016/j.expneurol.2009.06.015281050819576215
  66. 66. Huang C, Xiao X, Chintagari NR, Breshears M, Wang Y, Liu L. MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome. BMC Med Genomics. 2014;7:1-15.10.1186/1755-8794-7-46412853625070658
  67. 67. Ndegwa LK, Katz MA, McCormick K, et al. Surveillance for respiratory health care-associated infections among inpatients in 3 Kenyan hospitals. Am J Infect Control. 2014;42:985-990.10.1016/j.ajic.2014.05.02225179331
  68. 68. Wang J, Yu M, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394:184-188.10.1016/j.bbrc.2010.02.14520188071
  69. 69. Vasilescu C, Rossi S, Shimizu M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4:e7404.10.1371/journal.pone.0007405275662719823581
  70. 70. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009;380:437-441.10.1016/j.bbrc.2008.12.19019284987
DOI: https://doi.org/10.1515/jim-2017-0074 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 235 - 241
Submitted on: Jul 27, 2017
Accepted on: Aug 17, 2017
Published on: Nov 8, 2017
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Raluca Dumache, Alexandru Florin Rogobete, Dorel Sandesc, Ovidiu Horea Bedreag, Veronica Ciocan, Camelia Muresan, Adrian Tudor Stan, Mihai Sandesc, Anca Dinu, Sonia Elena Popovici, Alexandra Enache, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.